Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
1 clinical trials · Condition
◉ Watch Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
| Record | Firm | Date |
|---|---|---|
| Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma (NCT06514898) | University of Florida | 2025-05-05 |
Track Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma automatically
Every clearance here is in the API, with alerts when new ones post.